IL132897A0 - Process and intermediates for preparing 5-lipoxygenase inhibitors - Google Patents
Process and intermediates for preparing 5-lipoxygenase inhibitorsInfo
- Publication number
- IL132897A0 IL132897A0 IL13289799A IL13289799A IL132897A0 IL 132897 A0 IL132897 A0 IL 132897A0 IL 13289799 A IL13289799 A IL 13289799A IL 13289799 A IL13289799 A IL 13289799A IL 132897 A0 IL132897 A0 IL 132897A0
- Authority
- IL
- Israel
- Prior art keywords
- intermediates
- preparing
- lipoxygenase inhibitors
- lipoxygenase
- inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11322198P | 1998-12-22 | 1998-12-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL132897A0 true IL132897A0 (en) | 2001-03-19 |
Family
ID=22348241
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL13289799A IL132897A0 (en) | 1998-12-22 | 1999-11-11 | Process and intermediates for preparing 5-lipoxygenase inhibitors |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US6194585B1 (de) |
| EP (1) | EP1029865B1 (de) |
| JP (2) | JP3468729B2 (de) |
| KR (1) | KR100362789B1 (de) |
| CN (1) | CN1258675A (de) |
| AR (1) | AR019497A3 (de) |
| AT (1) | ATE265460T1 (de) |
| AU (1) | AU6539199A (de) |
| BR (1) | BR9905918A (de) |
| CA (1) | CA2289422A1 (de) |
| CZ (1) | CZ453699A3 (de) |
| DE (1) | DE69916778D1 (de) |
| HU (1) | HUP9904282A3 (de) |
| ID (1) | ID24014A (de) |
| IL (1) | IL132897A0 (de) |
| IN (1) | IN187165B (de) |
| PL (1) | PL337397A1 (de) |
| RU (1) | RU2181722C2 (de) |
| TR (1) | TR199903204A2 (de) |
| TW (1) | TW455586B (de) |
| YU (1) | YU59399A (de) |
| ZA (1) | ZA997113B (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4569187B2 (ja) * | 2004-06-17 | 2010-10-27 | 宇部興産株式会社 | ４−シアノテトラヒドロピランの製法 |
| US7674811B2 (en) | 2006-03-14 | 2010-03-09 | Ranbaxy Laboratories Limited | 5-lipoxygenase inhibitors |
| JP4469924B2 (ja) * | 2006-11-27 | 2010-06-02 | ファイザー・プロダクツ・インク | ピラゾール類似体 |
| SG175390A1 (en) | 2009-04-29 | 2011-12-29 | Amarin Corp Plc | Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same |
| WO2021133689A2 (en) * | 2019-12-23 | 2021-07-01 | Sri International | Lipoxygenase inhibitors |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0462830B1 (de) * | 1990-06-21 | 1995-10-18 | Zeneca Limited | Zyklische Ether-Derivate |
| IE913866A1 (en) * | 1990-11-28 | 1992-06-03 | Ici Plc | Aryl derivatives |
| EP0505122A1 (de) * | 1991-03-21 | 1992-09-23 | Zeneca Limited | Alpha, Alpha-Dialkylbenzylderivate |
| EP0540165A1 (de) * | 1991-10-03 | 1993-05-05 | Zeneca Limited | Alkonsäurederivate |
| EP0703913B1 (de) * | 1993-06-14 | 1997-06-11 | Pfizer Inc. | Imidazole als lipoxygenase inhibitoren |
| SK281577B6 (sk) * | 1994-10-18 | 2001-05-10 | Pfizer Inc. | Heterocyklické zlúčeniny a farmaceutický prostriedok na ich báze |
| US5883106A (en) * | 1994-10-18 | 1999-03-16 | Pfizer Inc. | 5-lipoxygenase inhibitors |
-
1999
- 1999-08-24 US US09/387,707 patent/US6194585B1/en not_active Expired - Fee Related
- 1999-11-11 IL IL13289799A patent/IL132897A0/xx unknown
- 1999-11-12 AT AT99309046T patent/ATE265460T1/de not_active IP Right Cessation
- 1999-11-12 CA CA002289422A patent/CA2289422A1/en not_active Abandoned
- 1999-11-12 DE DE69916778T patent/DE69916778D1/de not_active Expired - Lifetime
- 1999-11-12 EP EP99309046A patent/EP1029865B1/de not_active Expired - Lifetime
- 1999-11-15 ZA ZA9907113A patent/ZA997113B/xx unknown
- 1999-11-16 JP JP32599999A patent/JP3468729B2/ja not_active Expired - Fee Related
- 1999-11-16 HU HU9904282A patent/HUP9904282A3/hu unknown
- 1999-11-16 RU RU99124413/04A patent/RU2181722C2/ru not_active IP Right Cessation
- 1999-11-17 YU YU59399A patent/YU59399A/sh unknown
- 1999-11-17 TW TW088120072A patent/TW455586B/zh not_active IP Right Cessation
- 1999-11-18 IN IN814BO1999 patent/IN187165B/en unknown
- 1999-11-18 AR ARP990105879A patent/AR019497A3/es unknown
- 1999-11-22 ID IDP991082D patent/ID24014A/id unknown
- 1999-12-14 CZ CZ19994536A patent/CZ453699A3/cs unknown
- 1999-12-21 KR KR1019990059661A patent/KR100362789B1/ko not_active IP Right Cessation
- 1999-12-21 AU AU65391/99A patent/AU6539199A/en not_active Abandoned
- 1999-12-21 CN CN99126450A patent/CN1258675A/zh active Pending
- 1999-12-21 BR BR9905918-5A patent/BR9905918A/pt not_active IP Right Cessation
- 1999-12-22 PL PL99337397A patent/PL337397A1/xx not_active Application Discontinuation
- 1999-12-22 TR TR1999/03204A patent/TR199903204A2/xx unknown
-
2003
- 2003-05-13 JP JP2003134568A patent/JP2004002415A/ja not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JP2004002415A (ja) | 2004-01-08 |
| ID24014A (id) | 2000-06-22 |
| EP1029865A2 (de) | 2000-08-23 |
| CN1258675A (zh) | 2000-07-05 |
| DE69916778D1 (de) | 2004-06-03 |
| HUP9904282A3 (en) | 2001-04-28 |
| AU6539199A (en) | 2000-06-29 |
| JP3468729B2 (ja) | 2003-11-17 |
| IN187165B (de) | 2002-02-23 |
| US6194585B1 (en) | 2001-02-27 |
| YU59399A (sh) | 2002-11-15 |
| AR019497A3 (es) | 2002-02-20 |
| KR100362789B1 (ko) | 2002-11-30 |
| HU9904282D0 (en) | 2000-01-28 |
| JP2000191654A (ja) | 2000-07-11 |
| TW455586B (en) | 2001-09-21 |
| TR199903204A2 (xx) | 2000-07-21 |
| RU2181722C2 (ru) | 2002-04-27 |
| PL337397A1 (en) | 2000-07-03 |
| ZA997113B (en) | 2001-05-15 |
| CZ453699A3 (cs) | 2000-07-12 |
| ATE265460T1 (de) | 2004-05-15 |
| BR9905918A (pt) | 2000-09-26 |
| EP1029865A3 (de) | 2000-11-08 |
| HUP9904282A2 (hu) | 2000-12-28 |
| MX9912076A (de) | 2000-04-30 |
| KR20000052537A (ko) | 2000-08-25 |
| EP1029865B1 (de) | 2004-04-28 |
| CA2289422A1 (en) | 2000-06-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL353002A1 (en) | Hemisynthetic method and intermediates thereof | |
| CZ20012118A3 (cs) | Způsob výroby 3-alkanoylindolu a 3-alkylindolu | |
| EG23861A (en) | Intermediates and process for preparing olanzapine | |
| SG118060A1 (en) | Process for preparation of pyrazoloÄ4,3-dÜpyrimidin-7-ones and intermediates thereof | |
| HUP0101094A3 (en) | Process for preparing a protected 4-aminomethyl-pyrrolidin-3-one and intermediates | |
| HUP0101779A3 (en) | Process for de-chlorinating and de-fouling waste-oil | |
| GB2353974B (en) | Method of printing | |
| HUP0001813A3 (en) | Process for preparing eprosartan and intermediates | |
| GB9805028D0 (en) | Photobioreactor apparatus | |
| HU9904282D0 (en) | Process and intermediates for preparing 5-lipoxygenase inhibitors | |
| HUP0003019A3 (en) | Process for preparing 4-substituted-1h-indole-3-glyoxamides and their intermediates | |
| HUP0001444A3 (en) | Process for preparing carboxamido-4-azasteroids and their intermediates | |
| HUP0103002A3 (en) | New process for obtaining 17betha-(n-terc-butylcarbamoyl)-3-one-4-aza-steroids | |
| HUP0003438A3 (en) | Process for making 5-lipoxygenase inhibitor pirrole-carboxamid-derivatives and their intermediates | |
| HUP0003439A3 (en) | Process for making 5-lipoxygenase inhibitor pyrrole-carboxamid-derivatives and their intermediates | |
| HK1055962A1 (en) | Process for preparing discodermolide and analoguesthereof | |
| HUP9800619A1 (en) | Fermentation process | |
| HUP0101730A3 (en) | Method for preparing and using b-starch | |
| HUP9900121A3 (en) | Process for producing naphthyridones and intermediates | |
| HUP0104036A3 (en) | Process for preparing arylpiperidine carbinol intermediates and derivatives | |
| AU4295100A (en) | Process and intermediates for preparing benzodiazepines | |
| HUP0103679A3 (en) | Method for preparing 4-hydroxyquinolines and/or tautomeric forms | |
| PL333334A1 (en) | Method of obtaining silylethenes | |
| HU9903281D0 (en) | Method for recycling of grogs | |
| IL132405A0 (en) | Process and intermediates for preparing nicotinamide derivatives |